<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04605328</url>
  </required_header>
  <id_info>
    <org_study_id>Cesarean scar defect</org_study_id>
    <nct_id>NCT04605328</nct_id>
  </id_info>
  <brief_title>Cesarean Scar Defect (CSD); Prevalence, Risk Factors And Possible Associated Symptoms</brief_title>
  <acronym>isthmocele</acronym>
  <official_title>Cesarean Scar Defect (CSD); Prevalence, Risk Factors And Possible Associated Symptoms: A Cohort Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to detect the incidence of Cesarean Scar Defect (CSD) in women undergoing CS&#xD;
      in Women Health Hospital (WHH), assiut University, to identify risk factors for development&#xD;
      of CSD and identify the possible gynaecological symptoms related to CSD.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All eligible women, who will undergo CS in Women Health Hospital (WHH) will be seen on&#xD;
      regular visits to detect the presence of CSD by ultrasound and identify its characters and a&#xD;
      questionnaire will be fulfilled by the candidates about the gynecological symptoms related to&#xD;
      CSD and appeared after CS.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of CSD in Women health Hospital</measure>
    <time_frame>1 year</time_frame>
    <description>the incidence of CSD in Women health Hospital</description>
  </primary_outcome>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Cesarean Section Complications</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Two dimension and three dimension ultrasound</intervention_name>
    <description>Patient will undergo 2D and 3D ultrasound evaluation after CS for detection of CSD</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to Women Health Hospital for performing CS will be seen on regular visits&#xD;
        for ultrasound scan for detection of CSD&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All women who will undergo transverse lower segment cesarean section after 28 weeks&#xD;
             gestational age (electively and Emergency), after counseling and written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Rupture uterus (unscarred or scarred).&#xD;
&#xD;
          2. Upper segment CS.&#xD;
&#xD;
          3. Vertical lower segment CS.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ayman shamaash, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sherif Badran, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed Bahaa El-Dine, Master</last_name>
    <phone>++201022422960</phone>
    <email>midobahaa39@yahoo.com</email>
  </overall_contact>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 5, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2020</study_first_posted>
  <last_update_submitted>October 31, 2020</last_update_submitted>
  <last_update_submitted_qc>October 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohamed Bahaa</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>niche</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

